Wondering if Exor could be excellent value right now? You're not alone, especially with mixed signals swirling in global markets. Exor's stock saw a modest 1.6% climb over the last week, but it's ...

Exor (ENXTAM:EXO) has quietly slipped over the past year, with shares down around 23% even as its underlying holdings like Ferrari and Stellantis keep executing. That gap is exactly what value focused ...

Add Yahoo as a preferred source to see more of our stories on Google. Exor logo is seen on investor day held by holding group in Turin MILAN (Reuters) -Italy's Agnelli family, whose investments ...

Philips resolved the Respironics litigation, settling for $1.1 billion. And Exor decided to boost its stake in the company. Supportive shareholders' remuneration is linked to Exor's portfolio results, ...

Has already invested almost 4 bln euros in healthcare Has cash firepower of 1.7 bln euros already allocated To receive around 1.1 bln euros in dividends during 2024 Exor NAV rose to 35.5 bln euros ...

Exor faces challenges with Stellantis and CNH, but Ferrari's strong performance bolsters its financial stability. Exor's strategic shift towards luxury brands and healthcare indicates a potential move ...

MILAN, March 4 (Reuters) - Italy's Agnelli family has a 10.1% stake in New York-listed information services provider Clarivate 16A.F through their investment arm Exor EXOR.AS, the two companies said ...

Exor said on Tuesday it had completed the sale of reinsurer PartnerRe to France's Covea, providing a multibillion-euro warchest for acquisitions for the holding company of Italy's Agnelli family.